Phase II Study of Rituximab Combined With ESHAP in Patients With Relapse or Refractory DLBCL.
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2012
At a glance
- Drugs Rituximab (Primary) ; Cisplatin; Cytarabine; Etoposide; Methylprednisolone
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Acronyms ESHAP-DLBCL
- 18 Jan 2011 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 25 Dec 2007 New trial record.